ConclusionsYouth with type 2 diabetes exhibit complications sooner than youth with type 1 diabetes. Younger age at diagnosis is potentially protective, and glycemic control is an important modifiable risk factor. The unexpected adverse association between RAAS inhibitor use and outcome is likely a confounder by indication; however, further evaluation in young people is warranted.
PMID: 24130346 [PubMed – as supplied by publisher] (Source: Diabetes Care)
MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.